(Cincinnati, OH– July 14, 2021) – Roebling Capital Partners (“RCP” or “Roebling”), along with Strength Capital Partners (“Strength”) have completed a majority recapitalization of Chemlock Nutrition (the “Company”), a fast-growing, specialty feed additives company. The deal will facilitate Chemlock Nutrition’s investment in R&D, additional technical staff and new innovations that will help accelerate growth initiatives and expand capabilities of the Company, complementary to their ongoing success.
Arun Mehan and Kris Mehan, CEO and COO of Chemlock Nutrition, respectively, will retain substantial ownership positions in the Company.
“Chemlock Nutrition is one of the fastest growing companies in the U.S.,” said Keith Carlson, Managing Director and CEO of Roebling. “The deal represents exactly the type of companies Roebling wants to invest in – ones with strong management teams, financial stability, and potential to grow at a fast pace. Our partnership with Chemlock will provide the extra bit of capital and expertise they need to take the company to the next level.”
Arun Mehan echoes the sentiment about the impact the partnership will have. “We now will have the opportunity to assemble a very talented group of people at all levels, from the field to our Board of Directors, to help propel our growth, which is the most exciting thing about the deal.”
Chemlock Nutrition formulates and provides high-purity, specialty feed additives for end-use in the livestock feed industry. The Company has been at the leading edge of a transformation in the industry as consumer demand for healthier, more natural & organic options has risen. The Company’s products generally promote substantially more favorable animal health, and consequently, human health. Since entering the industry in 2013, Chemlock has become one of the fastest growing feed additive and ingredient companies in the US, having more than tripled its revenue in the last three years.
Kris Mehan further stated, “Our business is growing so rapidly that we have outgrown the size of our team. With the addition of outside capital, we can fund more research and staff that will help us close the gap between current meat/dairy production limitations and evolving consumer demand / climate change.” We call this next phase of growth ‘Chemlock 2.0’, as we put our focus on creating more products that help reduce antibiotic usage and reduce the meat and dairy industry’s environmental impact.
Additional terms of the deal have not been disclosed.
This communication does not constitute an offer to sell or the solicitation of an offer to buy any specific investment product sponsored by, or investment services provided by, RCP or its affiliates. Any such offer may be made only to qualified investors by means of delivery of a confidential Private Placement Memorandum or similar materials that contain a description of the material terms of such investment. No sale will be made in any jurisdiction in which the offer, solicitation, or sale is not authorized or to any person to whom it is unlawful to make the offer, solicitation or sale. Private investments involve a high degree of risk and therefore, should be undertaken only by prospective investors capable of evaluating and bearing the risks such an investment represents.